Zocilurtatug pelitecan
Zocilurtatug pelitecan (ZL-1310) is a blood-brain barrier-penetrating antibody-drug conjugate targeting DLL3. It consists of the antibody component Zocilurtatug (HY-P992148) and the toxin-linker molecule DL-01 (HY-155870). Zocilurtatug pelitecan induces cell cycle arrest and apoptosis in tumor cells, and inhibits the growth of established human tumors in xenograft models. It can be used in research on extensive-stage small cell lung cancer (SCLC) and neuroendocrine tumors.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 3058592-88-1
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Alle Topoisomerase Isoform-spezifische Produkte anzeigen
More
Biologische Aktivität
Zocilurtatug pelitecan (ZL-1310) binds specifically to DLL3 across species but not other Delta family members, and induces internalization, cell cycle arrest, and apoptosis in DLL3-expressing tumor cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS. Nr. 3058592-88-1
-
SMILES
[Zocilurtatug pelitecan]
-
Synonyms
ZL-1310
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)